from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3220c/-

LFCtreatmentdescriptionclass of inhibitor

-0.550

Amikacinug/mL Amikacintranslation

-0.492

Cap5-10ug/mL Capreomycintranslation

-0.666

Rox10-50 ug/mL Roxithromycintranslation

-0.231

SM2-5 ug/mL Streptomycintranslation

0.190

Tet5-10 ug/mL Tetracyclinetranslation

0.882

Rif0.2-5ug/mL Rifampicintranscription

-0.170

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.233

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.390

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-1.567

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.854

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.510

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.251

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.539

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.442

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.671

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.939

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.000

KCN5-20 ug/mL Potassium cyaniderespiration

0.432

NaN30.2-2 mM Sodium aziderespiration

-0.334

Nigericin50 uM Nigericinrespiration

-0.465

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

-0.851

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.509

menadione6-10 ug/mL Menadionerespiration

-0.555

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.274

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.139

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.285

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.445

NRP_1Non-replicating persistence stage 1dosRassociated

0.048

Amp0.2mg/mL AmpicillincellWall

0.550

Cephalexin20-100 ug/mL CephalexincellWall

-0.290

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.481

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.341

EMB10-20 ug/mL EthambutolcellWall

-0.048

Eta12-40 ug/mL EthionamidecellWall

0.943

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.417

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.000

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-2.075

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.440

BZA0.12 mg/mL BenzamidearomaticAmides

0.690

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.783

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.095

H2O24 mM hydrogen peroxideDNAdamaging

0.062

Levo10 ug/mL LevofloxacinDNAdamaging

0.226

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.000

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.190

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.434

UVUV-irradiationDNAdamaging

0.000

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.885

Antimycin12.5-50 ug/mL Antimycin A?

-1.810

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.290

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.570

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.480

PA8240.2-2 ug/mL PA-824?

1.445

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.378

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.682

Verapamil50 uM Verapamil?

-2.481

mercaptoethanol2 mM 2-Mercaptoethanol?

0.308

methoxatin10-20 ug/mL Methoxatin?